Rheumatoid arthritis (RA) is characterized by flare ups, which can be unpredictable. However, efforts in RNA-sequencing are already predicting flares with accuracy of up to 2 weeks before the episode.
​
In the ImYoo RA Working Group, we ask, "How are these flares triggered?" and "Why do biologics only work for some people?" Tell us which RA questions we need to research now - your question could be our next research idea!
ImYoo has partnered with Jumpcode Genomics to use Jumpcode’s RNA depletion technology to improve data quality and eliminate the uninformative sequences that were reduce the ability to gather valuable data at reasonable costs, using Jumpcode's CRISPRclean Single Cell RNA Boost Kit.
Read more at jumpcodegenomics.com:
ImYoo was selected as one of the award winners for QuickFire Immunology Challenge. As part of the award, ImYoo will receive lab space and access to the global Johnson & Johnson Innovation – JLABS (‘JLABS’) network and mentorship from experts across the Johnson & Johnson Family of Companies.
Read more at jnjinnovation.com:
